THE NUCLEAR FACTOR κB (NFκB) AND NOTCH SIGNALLING PATHWAYS AND BRCA1 MRNA EXPRESSION IN STAGE IV NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)

被引：0
|
作者：
Santarpia, Mariacarmela [1 ]
Sanchez-Ronco, Maria [2 ]
Magri, Ignacio
Angel Molina, Miguel
Viteri, Santiago
Costa, Carlota
Gasco, Amaya
Gonzalez-Cao, Maria
Mederos, Nuria
Salazar, Fernanda
Bertran-Alamillo, Jordi
Jimenez-Capitan, Ana
Altavilla, Giuseppe [1 ]
Benlloch, Susana
Yeste, Zaira
Aldeguer, Erika
Taron, Miquel [3 ]
Rosell, Rafael [3 ]
机构：
[1] Univ Hosp Policlin G Martino, Milan, Italy
[2] Univ Alcala de Henares, Alcala De Henares 99775, Spain
[3] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NFkB; Notch pathways; Non-Small-Cell Lung Cancer; BRCA1 mRNA expression;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S993 / S994
页数：2
相关论文
共 50 条
  • [21] Nuclear factor kappa B expression in non-small cell lung cancer
    Zhang, Leilei
    Ludden, Claudia M.
    Cullen, Alexander J.
    Tew, Kenneth D.
    de Barros, Andre Luis Branco
    Townsend, Danyelle M.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [22] Correlation between BRCA1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer
    Gachechiladze, Mariam
    Uberall, Ivo
    Kolek, Vitezslav
    Klein, Jiri
    Krejci, Veronika
    Stastna, Jitka
    Radova, Lenka
    Fridman, Eddie
    Skarda, Josef
    BIOMEDICAL PAPERS-OLOMOUC, 2013, 157 (03): : 227 - 232
  • [23] Treatment of elderly patients with stage IV non-small-cell lung cancer
    Weiss, Jared
    Stinchcombe, Thomas E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (01) : 111 - 120
  • [24] Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum
    Massuti, Bartomeu
    Cobo, Manuel
    Camps, Carlos
    Domine, Manuel
    Provencio, Mariano
    Alberola, Vicente
    Vinolas, Nuria
    Rosell, Rafael
    Taron, Miguel
    Gutierrez-Calderon, Vanesa
    Lardelli, Pilar
    Alfaro, Vicente
    Nieto, Antonio
    Isla, Dolores
    LUNG CANCER, 2012, 76 (03) : 354 - 361
  • [25] Influence of XPG mRNA levels on the effect of BRCA1 mRNA levels in prognosis of early non-small cell lung cancer (NSCLC)
    Bartolucci, R.
    Botia, M.
    Mendez, P.
    Puma, F.
    Sabatini, S.
    Catanzani, S.
    Urbani, M.
    Saccenti, P.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [27] Surgery for Elderly Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC)?
    Passlick, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S91 - S92
  • [28] A phase II study of erlotinib (E) and bevacizumab (B) in patients (pts) with previously untreated stage IIIB/IV non-small-cell lung cancer (NSCLC)
    Smit, Egbert F.
    Dingemans, Anne-Marie C.
    Groen, Harry J.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S411 - S411
  • [29] Increased BRCA1 mRNA: An independent prognostic variable in completely resected chemo-naive non-small cell lung cancer (NSCLC) patients (p)
    Rosell, R.
    Jassem, E.
    Skrzypski, M.
    Taron, M.
    Mendez, P.
    Perez, L.
    Szymanowska, A.
    Rzyman, W.
    Gulida, G.
    Jassem, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A phase II study of eirlotinib (E) and bevacizumab (B) in patients (pts) with previously untreated stage IIIB/IV non-small-cell lung cancer (NSCLC)
    Dingemans, A.
    Groen, H. J. M.
    Smit, E. F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 360 - 360
12345